Sarlósejtes vérszegénység: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• G6PD 0
• NLRP3 0
• APOL1 0
• CD19 3
• BTK 0
• FGFR 0
• NRF2 0
• SGLT2 1
• CFTR 1
• CXCR4 0
• DMD 1
• GLP-1 0
• HDAC 1
• HMGB1 0
• HTT 1
• JAK 0
• NF1 1
• SMN1 1

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH OD · C06

  BRF: LLU Cellular Therapy Research Facility

  Loma Linda University· Loma Linda, Egyesült Államok· 8 000 000 USD awarded in fiscal year 2026· until 2028. jan.

• NIH NHLBI · K24

  Translational Research in Sleep and Circadian Rhythms

  University of Alabama at Birmingham· Birmingham, Egyesült Államok· 71 934 USD awarded in fiscal year 2026· until 2031. máj.

• NIH FIC · R21

  Mobile Optical System for Stroke Risk Screening in Pediatric Sickle Cell Disease in Uganda

  Kennesaw State University· Kennesaw, Egyesült Államok· 179 988 USD awarded in fiscal year 2026· until 2028. jún.

• NIH NHLBI · K01

  Healthcare Stressors and Biobehavioral Stress Responses in Sickle Cell Disease: An Investigation of AYA and Clinical Factors

  Children's Hosp of Philadelphia· Philadelphia, Egyesült Államok· 168 156 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NHLBI · R03

  Dissecting von Willebrand factor secretory machinery for therapeutic vulnerabilities

  Yale University· New Haven, Egyesült Államok· 252 000 USD awarded in fiscal year 2026· until 2028. jún.

• European Commission (Horizon Europe) · HORIZON-ERC

  Innovating Sickle Cell Disease Treatment: From Non-Canonical Signaling and Immune Activation to Personalized Targeted Therapies (TARGET-SCD)

  Universite Paris Cite· Paris, Franciaország· EU contribution 2 449 320 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Deciphering Inflammatory and Placental Mechanisms of Pre-eclampsia in Sickle Cell Disease (PRECISE)

  Imagine Institut des Maladies Genetiques Necker Enfants Malades Fondation· Paris, Franciaország· EU contribution 242 261 EUR· until 2028. dec.· 2 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  A metabolic-based defense strategy against malaria (KILLBILL)

  Fundacao Gimm - Gulbenkian Institute for Molecular Medicine· Lisboa, Portugália· EU contribution 2 500 000 EUR· until 2031. szept.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-JU-CSA

  CONSORTIUM FOR DEVELOPING REGULATORY CAPACITY FOR CLINICAL TRIALS USING GENE THERAPY PRODUCTS AND STRENGTHENING PHARMACOVIGILANCE IN THE CONDUCT OF CLINICAL TRIALS IN EAST AFRICA (CAPACITY 2023)

  Universidade de Coimbra· Coimbra, Portugália· EU contribution 999 315 EUR· until 2027. márc.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Synthetic generation of hematological data over federated computing frameworks (SYNTHEMA)

  Universidad Politecnica de Madrid· Madrid, Spanyolország· EU contribution 6 514 560 EUR· until 2026. nov.· 10 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 348 running projects, newest first. Listed amounts together: 215,2 M USD + 25,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 1
• CRISPR-Cas Systems 15
• Gene Expression Profiling 7
• Exome Sequencing 1
• Proteomics 7
• Metabolomics 2
• Mass Spectrometry 2
• Flow Cytometry 5
• Immunohistochemistry 2
• Magnetic Resonance Imaging 21
• Machine Learning 5
• Deep Learning 3
• Cohort Studies 19
• Genome-Wide Association Study 5

• Risk factors for pediatric acute chest syndrome using machine learning techniques.

  Blood Adv, 2026. okt.

• Systematic review of machine learning approaches for predicting sickle cell crisis and mortality risk at the climate-health nexus.

  BMC Med Inform Decis Mak, 2026. szept.

• Label-free lateral shearing digital holographic imaging of red blood cells for sickle cell disease identification.

  J Opt Soc Am A Opt Image Sci Vis, 2026. aug.

• Regional brain age is decreased in children with sickle cell anemia.

  Blood Adv, 2026. febr.

• Artificial Intelligence-Based Analysis of Central Nervous System Vasculopathy in Pediatric Sickle Cell Anemia.

  Am J Hematol, 2026. febr.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.